Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19

Clinical trial NCT04371978 · TERMINATED

Trial details

NCT number: NCT04371978
Sponsor: Rabin Medical Center
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

COVID 19 Coronavirus Diabetes Mellitus, Type 2 Diabetes Mellitus Glucose Metabolism Disorders Metabolic Disease Endocrine System Diseases Dipeptidyl-Peptidase IV Inhibitors Linagliptin Severe Acute Respiratory Syndrome Coronavirus 2 Sars-CoV2 Hypoglycemic Agents

Start date: 2020-10-01
Primary completion: 2021-04-04
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.